TRACON Pharmaceuticals In... (TCON)
0.03
-0.00 (-6.83%)
At close: Feb 28, 2025, 3:00 PM
1.08
3254.04%
After-hours: Jun 27, 2024, 07:53 PM EDT
TRACON Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 8.56M | 17.43M | 24.07M | 32.13M | 16.41M | 25.14M | 29.47M | 35.71M | 41.37M | 35M | 2.28M | 2.46M |
| Short-Term Investments | n/a | n/a | n/a | 4M | n/a | 13.97M | 5M | 8.7M | 10.78M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 67K | 246K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 73K | 1.12M | 1.32M | 508K | 838K | n/a | n/a | n/a | 43K | 2.35M | 24K | 8K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 526K | 795K | 1.73M | 1.57M | 1.7M | 3M | 3.18M | 2.47M | 2.3M | 1.46M | 99K | 124K |
| Total Current Assets | 9.09M | 18.23M | 24.94M | 36.91M | 17.26M | 40.6M | 36.06M | 45.65M | 53.31M | 35.73M | 2.38M | 2.58M |
| Property-Plant & Equipment | 942K | 51K | 50K | 16K | 23K | 45K | 73K | 82K | 173K | 97K | 20K | 20K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.01M | 1.24M | 1.62M | 524K | 861K | 45K | 73K | 82K | 216K | 2.44M | 44K | 28K |
| Total Assets | 10.11M | 19.47M | 26.56M | 37.44M | 18.12M | 40.65M | 36.13M | 45.73M | 53.52M | 38.17M | 2.42M | 2.61M |
| Account Payables | 2.54M | 3.92M | 4.94M | 1.73M | 2.41M | 10.95M | 6.8M | 7.8M | 8.28M | 3.97M | 1.27M | 667K |
| Deferred Revenue | n/a | n/a | n/a | n/a | -7.52M | -10.95M | 667K | 1.26M | 3.35M | 4.36M | -1.27M | n/a |
| Short-Term Debt | 236K | 10.01M | 1.54M | 3.14M | 2.96M | 1.08M | 2.84M | -7.47M | 1.38M | 4.68M | 677K | n/a |
| Other Current Liabilities | 7.4M | 8.44M | 7.2M | 5.68M | 6.47M | 1.46M | 1.49M | 850K | 1.16M | 246K | 97K | n/a |
| Total Current Liabilities | 10.18M | 22.37M | 13.68M | 10.54M | 11.83M | 13.49M | 11.8M | 10.24M | 14.18M | 13.25M | 2.05M | 667K |
| Long-Term Debt | 732K | n/a | n/a | 1.39M | 2.74M | 5.34M | 4.6M | 7.13M | 7.46M | 4.26M | 1.76M | n/a |
| Other Long-Term Liabilities | n/a | 4.25M | n/a | 432K | 850K | 368K | 409K | 21K | 905K | 50.29M | 23.95M | 19.61M |
| Total Long-Term Liabilities | 732K | 4.25M | 1.17M | 1.82M | 3.59M | 5.71M | 7.34M | 7.15M | 8.37M | 57.09M | 25.72M | 19.61M |
| Total Liabilities | 10.91M | 26.62M | 14.84M | 12.37M | 15.42M | 19.21M | 19.14M | 17.39M | 22.54M | 70.34M | 27.76M | 20.27M |
| Total Debt | 968K | 9.81M | 1.39M | 4.53M | 5.34M | 6.43M | 7.44M | 7.46M | 8.84M | 8.93M | 2.44M | n/a |
| Common Stock | 44K | 23K | 19K | 15K | 4K | 30K | 18K | 16K | 12K | 2K | 2K | 2K |
| Retained Earnings | -240.5M | -236.91M | -207.78M | -179.11M | -162.33M | -139.66M | -104.7M | -85.6M | -58.59M | -34.18M | -27.37M | -19.66M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -128K | -100K | -176K | -82K | -113K | -98K | -91K |
| Shareholders Equity | -809K | -7.15M | 11.71M | 25.07M | 2.7M | 21.44M | 16.99M | 28.34M | 30.98M | -32.17M | -25.34M | -17.66M |
| Total Investments | 73K | 67K | 246K | 4M | n/a | 13.97M | 5M | 8.7M | 10.78M | n/a | n/a | n/a |